Topics

Propanc Biopharma gears up to file clinical trial application for its lead anti-cancer therapy PRP

09:15 EDT 15 Jul 2019 | Proactive Investors

CEO James Nathanielsz says the company is planning a first-in-human study by undertaking “full scale manufacturing” of PRP for human use

Original Article: Propanc Biopharma gears up to file clinical trial application for its lead anti-cancer therapy PRP

NEXT ARTICLE

More From BioPortfolio on "Propanc Biopharma gears up to file clinical trial application for its lead anti-cancer therapy PRP"

Quick Search